ADRIANNA HYAMS: Open Payments
NPI 1386179695 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,271 in 114 payments from 23 companies in 2025. Trend: 2023 $1,281 · 2024 $99 · 2025 $2,271
Food & beverage: $2,111Education: $160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $621 |
| Teva Pharmaceuticals USA, Inc. | 11 | $263 |
| Eisai Inc. | 6 | $190 |
| SK Life Science, Inc. | 8 | $178 |
| PFIZER INC. | 13 | $167 |
| CATALYST PHARMACEUTICALS, INC. | 4 | $98 |
| Lundbeck LLC | 5 | $92 |
| JAZZ PHARMACEUTICALS INC. | 3 | $84 |
| TG Therapeutics, Inc. | 3 | $81 |
| Neurelis, Inc. | 4 | $76 |
Products named: QULIPTA, Leqembi, UBRELVY, NURTEC ODT, AUSTEDO XR, FYCOMPA, VYEPTI, EPIDIOLEX.
Industry payments across IN — which companies pay providers there.
